Praxis Precision Medicines director Jill DeSimone disposes of common shares worth $3.23 million

Praxis Precision Medicines

Praxis Precision Medicines

PRAX

0.00
  • Praxis Precision Medicines director Jill DeSimone exercised stock options on June 24, acquiring 11,600 common shares at USD 44.25 and USD 147.3.
  • She sold 11,600 common shares the same day at prices mostly around USD 301.44 to USD 315.71.
  • DeSimone ended the day with 2,337 shares beneficially owned.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Praxis Precision Medicines Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001930479-26-000003), on June 26, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.